Amgen Inc (AMGN)

Return on assets (ROA)

Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020
Net income (ttm) US$ in thousands 4,090,000 4,230,000 3,130,000 3,763,000 6,717,000 7,566,000 7,979,000 7,917,000 6,552,000 6,835,000 6,576,000 5,723,000 5,893,000 5,609,000 5,746,000 7,085,000 7,264,000 7,352,000 7,299,000 7,675,000
Total assets US$ in thousands 91,839,000 90,883,000 90,907,000 92,980,000 97,154,000 90,534,000 90,269,000 88,720,000 65,121,000 63,700,000 59,294,000 59,196,000 61,165,000 64,993,000 59,773,000 62,539,000 62,948,000 64,637,000 65,011,000 61,669,000
ROA 4.45% 4.65% 3.44% 4.05% 6.91% 8.36% 8.84% 8.92% 10.06% 10.73% 11.09% 9.67% 9.63% 8.63% 9.61% 11.33% 11.54% 11.37% 11.23% 12.45%

December 31, 2024 calculation

ROA = Net income (ttm) ÷ Total assets
= $4,090,000K ÷ $91,839,000K
= 4.45%

Amgen Inc's return on assets (ROA) has displayed some variability over the past few years. The ROA was relatively stable around the 11% range from March 2020 to March 2021 before experiencing a decline to 9.61% by June 2021 and further dropping to 8.63% by September 2021. The ROA slightly rebounded to 9.63% by December 2021.

Throughout 2022 and the first half of 2023, the ROA continued to fluctuate within the range of 8.36% to 11.09%. However, there was a notable decline in ROA in the second half of 2023, reaching 6.91% by December 2023. This downward trend persisted into 2024, with the ROA declining further to 4.05% by March 2024, and reaching its lowest point at 3.44% by June 2024.

Although there was a slight uptick in ROA to 4.65% by September 2024 and 4.45% by December 2024, the overall trend indicates a decline in the return on assets for Amgen Inc. These decreasing ROA figures suggest a declining efficiency in generating profits from its assets, and Amgen may need to analyze and address the underlying factors contributing to this trend to improve its profitability in the future.


See also:

Amgen Inc Return on Assets (ROA) (Quarterly Data)